: The global leader in animal health, currently ranked as an "undervalued" wide-moat stock by Morningstar.
: Noted for its diversified pharma segment, particularly in immunology and oncology drugs like Darzalex and Erleada .
: Identified by Morningstar as one of the most undervalued wide-moat stocks, currently trading below its fair value. top pharma stocks to buy now
AI responses may include mistakes. For financial advice, consult a professional. Learn more The Best Healthcare Stocks to Buy | Morningstar
Table of Contents * The 12 Best Healthcare Stocks to Buy Now. * Coloplast. * Veeva Systems. * Philips. * Zoetis. * Novo Nordisk. * Morningstar : The global leader in animal health, currently
: Recognized for its strong clinical momentum in oncology and its leading HIV franchise, with consistent revenue growth reported recently. Global & High-Growth Tickers
: A staple for value investors, focusing on its next-generation immunology drugs to offset the patent loss of its blockbuster drug Humira. AI responses may include mistakes
: The top pick for those looking at Indian markets, cited as a long-term leader in specialty drugs.